ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade.

Paul Johannet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.